Petra Kaur Ljungman, with many years of experience from leading positions in the medical device and pharmaceutical industry, has been recruited for a newly established, global role as Chief Marketing and Communications Officer. She will take up her position in January 2021 and will report to the CEO.“Petra Kaur Ljungman has a broad experience...
Strong growth and earnings development in quarter affected by COVID-19Second quarter (April-June 2020) Revenues amounted to SEK 48,2 (33,0) million and increased by 46% (adjusted for currency 45%). EBITDA amounted to SEK 10,5 (5,7) million with an EBITDA-margin of 22% (17%). Operating profit amounted to SEK -0,8 (-4,8) million. Net profit/loss...
Health Canada has approved Bactiguard’s endotracheal tubes for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard’s endotracheal tubes can reduce the risk of secondary infections for critically ill patients. “Many critically ill COVID-19 patients require intubation with an endotracheal tube...
Bactiguard Holding AB (publ) publishes the interim report for the second quarter on Thursday August 13, 2020 at 7:30 CET.In connection with this, a webcast for investors, analysts and media will be held at 10:00 CET on August 13. CEO Cecilia Edström will present the interim report and answer questions. Bactiguard's new CFO Gabriella Caracciolo...
Bactiguard initiates collaboration with the online pharmacy Apotea on sales of Hydrocyn® aqua (Hydrocyn) to consumers in the Swedish market. Recent tests confirm that Hydrocyn is the first disinfectant on the Swedish market with documentet effect on the new Corona virus causing COVID-19. Sales via Apotea will commence on 5 June. “We are...
The effect of Hydrocyn® aqua (Hydrocyn) on the new coronavirus (SARS-CoV-2) causing COVID-19 has been confirmed. Tests performed by the Swedish National Veterinary Institute show that 99.9% of the virus particles were killed after exposure to Hydrocyn. Bactiguard launched Hydrocyn in the Swedish market in March, with focus on critical societal...
During May 2020, the number of class B shares in Bactiguard Holding AB (publ) ("Bactiguard") has increased by 241,512. As a result, the total number of shares in the company as of May 29, 2020 amounted to 29,543,885 and the total number of votes to 69,543,885.The increase is a result of the new issue of shares by way of set-off that was approved...
To contribute to the research on COVID-19, Bactiguard donates SEK 120,000 to Karolinska Institutet (KI) at Danderyd Hospital."We have collaborated with Karolinska Institutet at Danderyd Hospital (KI DS) since 2010, where we share lab resources to be able to test how Bactiguard's coating technology interacts with blood. In addition, Bactiguard has...
The development of the Covid-19 pandemic has painfully highlighted the urgent need for infection prevention. This has led to an increased interest in Bactiguard and generated strong sales from mid-March. Total revenues increased by more than 40 percent in the quarter and EBITDA doubled, generating an EBITDA margin of 30 percent and a positive net...
Bactiguard Holding AB (publ) has appointed Gabriella Björknert Caracciolo, currently Head of Strategy, Development and Governance within Transaction Banking, Nordea as new CFO and Executive Vice President. She succeeds Cecilia Edström, who in February was appointed CEO of the company. Gabriella Björknert Caracciolo assumes her new position in...
Bactiguard Holding AB (publ) publishes the interim report for the first quarter on Wednesday May 13, 2020 at 8:00 CET.In connection with this, a webcast for investors, analysts and media will be held at 10:00 CET on May 13. CEO Cecilia Edström and acting CFO Lina Arverud will present the interim report and answer questions. The report and a...
At Bactiguard Holding AB’s (publ) Annual General Meeting (AGM) on 28 April, 2020, the following resolutions were made:The AGM adopted the income statements and balance sheets for 2019 and decided that no dividend for the financial year 2019 will be paid. Share premium reserve, retained earnings and the company's loss for the year will be carried...
The Annual General Meeting will be held on Tuesday, 28 April 2020 at 2:00 pm at the company´s head office at Alfred Nobels Allé 150 in Tullinge. Due to the outbreak of the Covid-19 virus and for the safety of Bactiguard shareholders, the company urges all shareholders not to participate personally, but instead take advantage of the opportunity...
For patients in intensive care, surgery and other conditions where continuous temperature monitoring is important, Bactiguard launches a new urinary catheter – BIP Foley TempSensor. In the same way as other Bactiguard products, BIP Foley TempSensor also prevents infections.“The global Covid-19 pandemic we are now experiencing has painfully...
The annual report for Bactiguard Holding AB (publ) 2019 is now available at www.bactiguard.com The annual report in Swedish is now available as a downloadable PDF document. An English version will be available shortly. A printed version of the report will be available from April 28 and can be ordered by email to: info@bactiguard.se. This...
The shareholders of Bactiguard Holding AB (publ), company reg. no. 556822-1187 (“Bactiguard”), are hereby given notice to attend the Annual General Meeting to be held on Tuesday, 28 April 2020 at 2:00 pm at the company´s head office at Alfred Nobels Allé 150 in Tullinge. Registration will commence at 1 pm. Right to participate and notice of...
Bactiguard launched the disinfectant HYDROCYN aqua® in Sweden at the beginning of March and, since then, demand has been high. As late as this weekend, products were flown in from the company's production facility in Malaysia via a newly established air bridge. Now, work is in progress to start production in Sweden as well. “In times like...
The rapid spread of the virus pandemic has led to a large number of countries closing their borders and transport capacity disappearing, as airlines discontinue routes and cancel departures. The effects on the global economy and trade are significant and will lead to uncertain supply of goods and difficulties in increasing delivery capacity for...
Bactiguard Holding AB (publ) ("Bactiguard"), BACTI, has received orders from customers, including the Police Authority, at a total value of over SEK 20 million within the first few days of the launch of HYDROCYN aqua® on the Swedish market. We will initially prioritize customers with critical societal functions and, at the same time, work on...
Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15–30 seconds. Previous experience shows that the proven effect can be transferred to new variants of coronavirus and tests on COVID-19 (SARS-CoV-2) are now underway at the Karolinska...
In the fight against the Corona virus, Bactiguard donates products for infection prevention to Chinese hospitals, at a market value of over 2 million SEK.“To help fight the new corona virus (covid-19) and protect the most severely ill patients, we will donate products from Bactiguard’s and Vigilenz's combined product portfolios to China”,...
Bactiguard Holding AB (publ) (“Bactiguard”) has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020.All conditions precedent have been fulfilled and the first part of the total consideration, consisting of a cash payment of USD 4.5 million, has been...
A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard's history. The financial effects of both increased BIP sales and new license revenues clearly show that our growth strategy works.Fourth quarter (October-December 2019) Revenues amounted to SEK 61.6...
Christian Kinch today announced to the Board that he will resign as CEO of Bactiguard Holding AB (publ) after close to 16 years. The Board has appointed CFO and Deputy CEO Cecilia Edström as new CEO of Bactiguard and Stefan Grass (CMO) as Deputy CEO. Until a permanent CFO has been recruited, Financial manager Lina Arverud will hold the position...
Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz) in Malaysia. The acquisition strengthens Bactiguard’s position in infection control and wound management, as well as innovation and product development capability and capacity. The...
Bactiguard Holding AB (publ) publishes the year end report for 2019 on Wednesday, February 5, 2020 at 8:00 CET.In connection with this, a web conference for investors, analysts and media will be held at 10:00 CET on February 5. CEO Christian Kinch and CFO Cecilia Edström will present the year end report and answer questions. The year end report...
